[Present and future indications of G-CSF in breast cancer].
Chevallier
B
B
Centre Henri-Becquerel, Rouen, France.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*
D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor